Amylin, another gut-related hormone (co-secreted with insulin), also suppresses appetite and glucagon; the amylin analog pramlintide is approved for diabetes, and longer-acting amylin or amylin-plus-peptide co-agonists are advancing in obesity pipelines [90]. This evidence concerns the gene IAPP and obesity disorder.